Casey C. Kopczynski - 18 Mar 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC

Role: Chief Scientific Officer
Signature: /s/ John LaRocca, Attorney-In-Fact for Casey Kopczynski
Issuer symbol: N/A
Transactions as of: 18 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Mar 2022, 20:32:38 UTC
Previous filing: 09 Feb 2022
Next filing: 21 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AERI	Common Stock	Award	$0	+19,015	+7.3%	$0.000000	280,244	18 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AERI	Stock Option (right to buy)	Award	$0	+65,941		$0.000000	65,941	18 Mar 2022	Common Stock	65,941	$8.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of March 18, 2022.
F2	This Option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of March 18, 2022.